Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,881 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study.
Osorio M, Gracia E, Rodríguez E, Saurez G, Arango Mdel C, Noris E, Torriella A, Joan A, Gómez E, Anasagasti L, González JL, Melgares Mde L, Torres I, González J, Alonso D, Rengifo E, Carr A, Pérez R, Fernández LE. Osorio M, et al. Among authors: perez r. Cancer Biol Ther. 2008 Apr;7(4):488-95. doi: 10.4161/cbt.7.4.5476. Epub 2007 Jan 2. Cancer Biol Ther. 2008. PMID: 18285705 Clinical Trial.
Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.
Crombet T, Osorio M, Cruz T, Roca C, del Castillo R, Mon R, Iznaga-Escobar N, Figueredo R, Koropatnick J, Renginfo E, Fernández E, Alvárez D, Torres O, Ramos M, Leonard I, Pérez R, Lage A. Crombet T, et al. Among authors: perez r. J Clin Oncol. 2004 May 1;22(9):1646-54. doi: 10.1200/JCO.2004.03.089. J Clin Oncol. 2004. PMID: 15117987 Clinical Trial.
Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc.
Oliva JP, Valdés Z, Casacó A, Pimentel G, González J, Alvarez I, Osorio M, Velazco M, Figueroa M, Ortiz R, Escobar X, Orozco M, Cruz J, Franco S, Díaz M, Roque L, Carr A, Vázquez AM, Mateos C, Rubio MC, Pérez R, Fernández LE. Oliva JP, et al. Among authors: perez r. Breast Cancer Res Treat. 2006 Mar;96(2):115-21. doi: 10.1007/s10549-005-9064-0. Epub 2005 Dec 2. Breast Cancer Res Treat. 2006. PMID: 16322892 Clinical Trial.
2,881 results